SC
UPI

Sophrosyne Capital’s UROPLASTY INC-NEW UPI Stock Holding History

Sophrosyne Capital’s Portfolio UPI Stock Details UPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-172,600
Closed -$463K – 77
2014
Q2 		$463K Hold
172,600
– – 0.47% 40
2014
Q1 		$627K Sell
172,600
-11,100
-6% -$43.4K 0.55% 37
2013
Q4 		$501K Sell
183,700
-45,000
-20% -$137K 0.44% 35
2013
Q3 		$757K Buy
+228,700
New +$639K 0.5% 42

Other funds holding UPI

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
MHP
Manatuck Hill Partners Westport, Connecticut $370M AUM 95.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
AC
Amici Capital New York $257M AUM 4.88% 1-Year Est. Return
RCP
Rothschild Capital Partners New York $408M AUM 25.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Sophrosyne Capital's UPI Position: Q3 2014 in Review

Sophrosyne Capital sold out of UROPLASTY INC-NEW (UPI) in Q3 2014, closing a stake of 172,600 shares — an estimated $463K sold.

Sophrosyne Capital first reported a position in UPI in Q3 2013 and held it in 4 quarters. The position peaked at $757K in Q3 2013. 31 funds tracked by Wall St. Rank hold UPI as of Q3 2014.

  • Sophrosyne Capital reported no remaining UROPLASTY INC-NEW position as of Q3 2014 after selling out during the quarter.
  • Sophrosyne Capital sold 172,600 UROPLASTY INC-NEW shares in Q3 2014, an estimated $463K.
  • Sophrosyne Capital first reported a position in UROPLASTY INC-NEW in Q3 2013 and held it in 4 quarters.
  • Sophrosyne Capital's UROPLASTY INC-NEW position peaked at $757K in Q3 2013.
  • 31 funds tracked by Wall St. Rank held UROPLASTY INC-NEW as of Q3 2014.

Based on Sophrosyne Capital's 13F filing for Q3 2014, filed 14 Nov 2014.